Identification of two novel mutations in non‐Jewish factor XI deficiency
- 1 August 1995
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 90 (4) , 916-920
- https://doi.org/10.1111/j.1365-2141.1995.tb05215.x
Abstract
We have studied two heterozygous unrelated CRM- non-Jewish FXI-deficient patients. Neither of the patients carries a previously described mutation. Their FXI genes were screened by SSCP analysis following PCR amplification of each exon and the flanking intronic sequences. DNA fragments showing aberrant mobility were cloned and sequenced. The following mutations were identified: in case 1, a T to G transition in exon 12 results in the substitution of Phe-442 by Val (FXI-F442V); in case 2 a C to A transition in exon 5 results in the substitution of Cys-128 by a nonsense codon (FXI-C128X). The missense mutation results in a substitution within the protease domain of FXI. Molecular modelling locates this residue in a structurally conserved region of the protease domain and the amino acid substitution may therefore interfere with either chain folding and subsequent secretion or the stability of the protein in plasma. We conclude that the mutations which we have identified are responsible for the inherited abnormality in these patients.Keywords
This publication has 21 references indexed in Scilit:
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991
- PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA.Genome Research, 1991
- Factor XI Deficiency in Ashkenazi Jews in IsraelNew England Journal of Medicine, 1991
- Comparative modeling methods: Application to the family of the mammalian serine proteasesProteins-Structure Function and Bioinformatics, 1990
- Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations.Proceedings of the National Academy of Sciences, 1989
- Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4Cytogenetic and Genome Research, 1989
- New amber mutation in a beta-thalassemic gene with nonmeasurable levels of mutant messenger RNA in vivo.Journal of Clinical Investigation, 1988
- Nonsense mutation causing steroid 21-hydroxylase deficiency.Journal of Clinical Investigation, 1988
- Nonsense mutations in the human beta-globin gene affect mRNA metabolism.Proceedings of the National Academy of Sciences, 1988
- Organization of the gene for human factor XIBiochemistry, 1987